(Total Views: 99)
Posted On: 12/18/2023 9:55:48 AM
Post# of 124260
$CYCC News Article - Cyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletions https://marketwirenews.com/news-releases/cycl...21305.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
